田辺三菱製薬プレスリリース・テンプレート設定用

First Page		Document Content
Date: 2013-05-26 10:08:55 Medicine Sodium-glucose transport proteins SLC5A2 Hyperglycemia Diabetes mellitus Diabetes management Canagliflozin Blood sugar Insulin Diabetes Endocrine system Biology		田辺三菱製薬プレスリリース・テンプレート設定用 Add to Reading List Source URL: www.mt-pharma.co.jp Download Document from Source Website File Size: 21,10 KB Share Document on Facebook

	DOCX Document DocID: 17hG7 - View Document
	CLINICAL SGLT2 inhibition with dapagliflozin Gary Kilov Stephen Leow DocID: 1465v - View Document
	Microsoft Word - final_150414_e.docx DocID: 13VvB - View Document
	License Agreement of SGLT2 Inhibitor “CSG452” in Japan DocID: ZwJo - View Document
	Forxiga_12_04_PR_antidiabetic DocID: RJQ3 - View Document